Products

99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam

China 99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam, Find details about China Levetiracetam, Levetiracetam Powder from 99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam

Model NO.
TGY201904170704
Appearance
White Crystalline Powder
Molecular Formula
C8h14n2o2
MW
243.30098
Certificate
ISO 9001, USP
Shelf Life
24 Months
Storage
Cool Dry Area
Grade
Pharmaceutical Grade
CAS No.
102767-28-2
Sample
Avaliable
Service
OEM
MOQ
20mg
Assay
98%Min, 99% HPLC
Test Method
USP;GMP
Einecs No.
600-348-9
Usuage
Antiepileptic
Trademark
TGY
Transport Package
Boil Bag
Specification
HPLC 99%
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29337900
Model NO.
TGY201904170704
Appearance
White Crystalline Powder
Molecular Formula
C8h14n2o2
MW
243.30098
Certificate
ISO 9001, USP
Shelf Life
24 Months
Storage
Cool Dry Area
Grade
Pharmaceutical Grade
CAS No.
102767-28-2
Sample
Avaliable
Service
OEM
MOQ
20mg
Assay
98%Min, 99% HPLC
Test Method
USP;GMP
Einecs No.
600-348-9
Usuage
Antiepileptic
Trademark
TGY
Transport Package
Boil Bag
Specification
HPLC 99%
Origin
Xi′an, Shaanxi, China (Mainland)
HS Code
29337900

99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam


Product Name
 		Levetiracetam 

Synonyms
 		Levetiracetam  Powder
CAS
102767-28-2
 
MF
 C8H14N2O2
 
MW
170.20896
 
Purity
99% HPLC
 
Appearance
white crystalline powder
 
Certification
USP, BP, GMP
 
Standard
Enterprise standard
 
Grade
Pharmaceutical grade
 
Usage
Antiepileptic
 
Storage
Store in a cool and dry area and keep away from direct sunlight
 
 


99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam
99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam
Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonic
seizures. Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of
partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures.Levetiracetam has been shown
to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar
purposes. Based on low-quality evidence, levetiracetam is about as effective as phenytoin for prevention of early seizures
after traumatic brain injury.
 


Name of Product
 		LEVETIRACETAM

Characters
 		White Or  White crystals Powder

Identification
 		 

A:Specific optical rotation
 		-76°to -82°
B:IRThe spectrum obtained from samples consists with that obtained from reference substance

C:Enantiomeric purity
 		Meet the requirement (see tests)

TESTS
 		 
Appearance of solution
 		Clear and not more intensely coloured than BY6

Enantiomeric purity (impurity D )
 		Not more than 0.8%

Related substances
 		 

Impurity A
 		Not more than 0.3%

Unspecified impurity
 		Not more than 0.05%

Sunof unspecified impurities
 		Not more than 0.1%

Total impurities
 		Not more than 0.4%

Impurity F
 		Not more than 0.1%

Heavy metals
 		Not more than 10ppm

Water
 		Not more than 0.5%

Sulfated Ash
 		Not more than 0.1%

Residual solvents
 		 

Acetone
 		Not more than 5000ppm

Assay Dichloromethane
 		Not more than 600ppm

Ethyl acetate
 		Not more than 5000ppm

Benzene
 		Not more than 2ppm

Assay (on anhydrous basis )
 		98.0%-102.0% OF C8H4N2O2


99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam

Levetiracetam is suitable for assistant treatment of partial or secondary generalized epileptic seizures in adult epilepsy patients.


99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam

1) Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case

of partial seizures

2) Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome

3) It is also sometimes used to treat neuropathic pain

99% USP35 GMP Levetiracetam Antiepileptic API Levetiracetam

You Might Also Like